US 12202822
Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition
granted A61PA61P37/06
Quick answer
US patent 12202822 (Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition) held by SuZhou Connect Biopharmaceuticals, Inc. expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SuZhou Connect Biopharmaceuticals, Inc.
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P37/06